Chief Financial Officer @ (August 2021 - April 2025)
Member of the Board of Advisors @ (July 2024 - Present)
Chief Financial Officer @ (May 2018 - August 2021)
SVP of Business Development @ (September 2015 - May 2018)
Managing Director, Co-Head of Healthcare Investment Banking @ (November 2012 - August 2015)
Managing Director @ Thinkequity LLC (July 2009 - November 2012)
Executive Director @ (January 2008 - April 2009)
Executive Director @ Cibc World Markets (March 2000 - January 2008)
Associate @ (January 1998 - January 2000)
Josh Muntner Education
University Of California - Los Angeles
Master of Business Administration (Finance)
1996-1998
Carnegie Mellon University 1986-1990
Josh Muntner Skills
Investment Banking
IPO
Secondary Offerings
PIPEs
Corporate Finance
M&A experience
Mergers
Valuation
Venture Capital
Biotechnology
Pharmaceuticals
Capital Markets
Equity Valuation
Lifesciences
Mergers & Acquisitions
Private Equity
Financial Analysis
Corporate Development
Portfolio Management
Financial Modeling
Start-ups
Competitive Analysis
Equity Capital Markets
Due Diligence
Divestitures
Investments
Private Placements
Capital Raising
Equities
Securities
Hedge Funds
Pharmaceutical Industry
Acquisitions
Emerging Markets
Investor Relations
LBO
Alternative Investments
Asset Management
Public Speaking
Microsoft Office
Management
Business Analysis
Mergers and Acquisitions
Start Ups
Business Development
Strategy
Josh Muntner Summary
Josh Muntner, based in New York, NY, US, is currently a Consulting Chief Financial Officer at Imvax, Inc.. Josh Muntner brings experience from previous roles at Imvax, Inc., Life Science Cares New York, Mesoblast Limited and ContraFect Corp. Josh Muntner holds a 1996 - 1998 Master of Business Administration in Finance @ University Of California - Los Angeles. With a robust skill set that includes Investment Banking, IPO, Secondary Offerings, PIPEs, Corporate Finance and more. Josh Muntner has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Josh Muntner?
Find contact details for 700 million professionals.